Uncovering Parkinson’s Biomarkers Through Red Blood Cell Proteins
Red blood cells (RBCs) offer a unique and minimally invasive window into neurodegeneration, yet their potential as a source of Parkinson’s disease biomarkers is only beginning to be explored.
This webinar will showcase state-of-the-art mass spectrometry (MS) platforms that are able to identify protein signatures linked to earlier detection and improved disease monitoring. Our expert speaker will share new findings from RBC proteomics research, offering attendees a look at how this exciting area of proteomics and high-resolution MS may advance our understanding and clinical management of Parkinson’s disease.
Attend this webinar to:
- Understand the rationale for using RBCs in biomarker discovery for Parkinson’s disease
- Learn how advanced MS workflows, such as data-independent acquisition and trapped ion mobility spectrometry – time-of-flight, enable deep proteome coverage
- Review bioinformatics and statistical approaches for candidate biomarker identification and validation
- Explore the translational potential of RBC proteomics for clinical applications
Presenter: Blaine Roberts, PhD (Associate Professor Department of Biochemistry, Emory University)
Dr. Roberts is an Associate Professor in the Department of Biochemistry and Department of Neurology at Emory University. He obtained his Bachelor of Science in Chemistry at Montana State University and his PhD in Biochemistry and Biophysics from Oregon State University. His research group focuses on using protein biochemistry and mass spectrometry to understand Alzheimers, Parkinson’s and amyotrophic lateral sclerosis. He has interest in understanding the role of metals in biology and has developed new proteomic technologies to measure metalloproteins. Further, his group is using mass spectrometry and next generation quantitative assays for the development of new blood borne biomarkers for Alzheimers and Parkinson’s disease.
